Company Filing History:
14 out of 164 
10 out of 38 
7 out of 53 
Years Active: 1997-2017
Title: Odile Esther Levy: Innovator in Polypeptide Technologies
Introduction
Odile Esther Levy, based in San Diego, CA, is a prominent inventor known for her significant contributions in the field of engineered polypeptides. With a remarkable portfolio of 29 patents, her work focuses primarily on developing compounds that enhance therapeutic effects for various metabolic and neurological disorders.
Latest Patents
Among her most recent inventions is a patent for "Engineered Polypeptides Having Enhanced Duration of Action." This innovation introduces compounds that possess remarkable qualities such as good duration of action, high potency, and convenient dosing regimens, including oral administration. The engineered polypeptides are designed to incorporate an albumin-binding domain, thereby enhancing their therapeutic effectiveness against a range of diseases and disorders, including obesity, diabetes, Alzheimer's disease, and cardiovascular issues.
Another noteworthy invention is her patent for "Hybrid Polypeptides with Selectable Properties." This invention pertains to novel hybrid polypeptides that serve as agents for treating and preventing metabolic diseases. They focus on controlling plasma glucose and insulin levels, tackling various conditions such as hypertension, obesity, and different forms of diabetes, including type 1 and type 2.
Career Highlights
Odile has garnered substantial experience working with reputed companies in the pharmaceutical industry. She has been associated with Amylin Pharmaceuticals and AstraZeneca Pharmaceuticals, where her expertise in biopharmaceutical development has been instrumental in advancing innovative therapeutic applications.
Collaborations
Throughout her career, Odile Levy has collaborated with esteemed colleagues such as Soumitra S Ghosh and Lawrence J D'Souza. These partnerships have played a crucial role in fostering innovation and research in the development of new therapeutic strategies.
Conclusion
Odile Esther Levy stands out as a leading inventor in the realm of polypeptide technologies, demonstrating a commitment to addressing critical health issues through her innovative work. With her extensive patent portfolio and collaborations in the pharmaceutical sector, she continues to make a significant impact on medical science and patient care.